ABAlexandre Bône

Alexandre Bône

*This is an algorithmically generated author record based on publicly available information.

Alexandre Bône has a total of 151 co-authors. Here are the top co-authors by number of shared publications:

  • Stanley Durrleman

    ARAMIS Lab, ICM, Inserm U1127, CNRS UMR 7225, Sorbonne University, Inria, Paris, France

    10 shared publications
  • Olivier Colliot

    6 shared publications
  • François Nicolas

    Guerbet Research, Villepinte, France

    4 shared publications
  • Maxime Louis

    Institut du Cerveau et de la Moelle épinière, ICM, Paris, F-75013, France; Inserm, U 1127, Paris, F-75013, France; CNRS, UMR 7225, Paris, F-75013, France; Sorbonne Université, Paris, F-75013, France; Inria, Aramis project-team, Paris, F-75013, France

    4 shared publications
  • Corinne Balleyguier

    Department of Medical Imaging, Gustave Roussy Cancer Campus, University Paris-Saclay, 94805 Villejuif, France; Biomaps, UMR1281 INSERM, CEA, CNRS, University Paris-Saclay, Institut Gustave Roussy, 94800 Villejuif, France

    3 shared publications
  • Jules Dupont

    Department of Diagnostic Oncologic Imaging, Gustave Roussy Institute, Villejuif F-94805, France; Biomaps, UMR1281, INSERM, Centre National de la Recherche Scientifique (CNRS), Commissariat à l'Energie Atomique (CEA), Université Paris Saclay, Villejuif 94800, France

    3 shared publications

Latest Publications

  • Open Access

    An interpretable deep learning method for early hepatocellular carcinoma diagnosis on multiphase CT

    by Emma Sarfati, Alexandre Bône, Pietro Gori, Sisi Yang, Marc-Michel Rohé, François Nicolas, Jeong-Min Lee, Jeong Hee Yoon, Maxime Ronot, Isabelle Bloch, et al.

    Early diagnosis of hepatocellular carcinoma is critical to preserve access to curative treatment options. The Liver Imaging Reporting and Data System (LI-RADS) provides a standardized framework for non-invasive diagnosis on multiphase computed tomography, based on major visual imaging features. However, these features may be difficult to assess consistently, particularly in small liver lesions. We developed dLI-RADS, an interpretable artificial intelligence method designed to estimate the probability of hepatocellular carcinoma from multiphase computed tomography images of manually segmented liver lesions, while remaining aligned with LI-RADS-related imaging concepts. dLI-RADS combines neural network-derived predictions with handcrafted quantitative imaging measurements reflecting LI-RADS major features and integrates these inputs using logistic regression. In this multicenter retrospective study, patients with multiphase computed tomography and at least one liver lesion were included, while lesions larger than 40 mm were excluded. Histology served as the reference standard for hepatocellular carcinoma, and a composite reference standard was used for non-hepatocellular carcinoma lesions. The lesion-level accuracy of dLI-RADS and LI-RADS were compared on the internal evaluation set using 10,000-repetition bootstrap non-inferiority tests, with 5% margins and significance levels. On the external test set, sensitivities were similarly compared. A total of 143 (61 years ± 9, 125 men), 62 (61y ± 10, 49 men), and 133 (59y ± 10, 103 men) patients with 196, 84, and 171 lesions (mean diameter 17.7, 18.3, and 21.8 millimeters) were respectively included in the training, internal and external evaluation sets. dLI-RADS was non-inferior to LI-RADS for lesion-level accuracy in the internal evaluation set, achieving 80% accuracy compared with 74% for LI-RADS ( p = 0.04). On the external evaluation set, dLI-RADS achieved a sensitivity of 93% compared with 78% for LI-RADS (non-inferiority p < 0.001). On this same set, dLI-RADS also achieved 74% specificity, 86% accuracy, and an AUC of 84%. Because LI-RADS features were unavailable for non-HCC lesions, only sensitivity could be directly compared between dLI-RADS and LI-RADS. These findings suggest that dLI-RADS may provide interpretable decision support for hepatocellular carcinoma diagnosis on multiphase computed tomography, particularly for small liver lesions.

  • Learning adapted coordinate systems for the statistical analysis of anatomical shapes. Applications to Alzheimer's disease progression modeling

    by Alexandre BônE

    Apprentissage de systèmes de coordonnées adaptés pour l'analyse statistique de formes anatomiques. Applications à la modélisation de la progression de la maladie d'Alzheimer: Cette thèse construit des systèmes de coordonnées pour formes, c'est-à-dire des espaces métriques de dimension finie où les formes sont représentées par des vecteurs. Construire de tels systèmes de coordonnées permet de faciliter l'analyse statistique de collections de formes. Notre motivation finale est de prédire et de sous-typer la maladie d'Alzheimer, en se basant notamment sur des marqueurs ainsi extraits de banques d'images médicales du cerveau. Même si de telles banques sont longitudinales, la variabilité qu’elles renferment reste principalement due à la variabilité inter-individuelle importante et normale du cerveau. La variabilité due à la progression d’altérations pathologiques est d'une amplitude beaucoup plus faible. L'objectif central de cette thèse est de développer un système de coordonnées adapté pour l'analyse statistique de banques de données de formes longitudinales, capable de dissocier ces deux sources de variabilité. Comme montré dans la littérature, le transport parallèle peut être exploité pour obtenir une telle dissociation, par exemple en définissant la notion d’exp-parallélisme sur une variété. Utiliser cet outil sur un espace de formes s'accompagne cependant de défis théoriques et calculatoires, relevés dans la première partie de cette thèse. Enfin, si en anatomie computationnelle les espaces de formes sont communément équipés d'une structure de variété, les classes de difféomorphismes sous-jacentes sont le plus souvent construites sans tenir compte des données étudiées. Le dernier objectif majeur de cette thèse est de construire des systèmes de coordonnées de déformations où le paramétrage de ces déformations est adapté aux données d'intérêt.

  • A Deep Learning Algorithm for Liver Metastasis Detection at Contrast-enhanced Abdominal CT in Patients with Colorectal Cancer: A Comparative Study with Radiologists

    by Riccardo Sartoris, Anita Paisant, Alexandre Bône, François Nicolas, Sonaz Malakzadeh, Francesco Matteini, Marco Dioguardi Burgio, Valérie Vilgrain, Maxime Ronot, Christophe Aubé

    A deep learning algorithm achieved liver metastasis detection rates on contrast-enhanced abdominal CT scans comparable to those of radiologists, with consistent performance across different lesion sizes, locations, and clinical conditions.


  • Understanding the challenges to implementing AI solutions in radiology departments and how to overcome them: A comprehensive review endorsed by the French College of Radiologists (CERF) and the French Society of Radiology (SFR)

    by Amandine Crombé, Camille Bourillon, Stéphane Chaillou, Clara Bechet, Jules Dupont, Alexandre Bône, Fanny Louvet-De Verchère, Alain Luciani, Marie-France Bellin, Christophe Aubé, et al.


  • The correlation of liquid biopsy genomic data to radiomics in colon, pancreatic, lung and prostatic cancer patients

    by Antoine Italiano, Othilie Gautier, Jules Dupont, Tarek Assi, Lama Dawi, Littisha Lawrance, Alexandre Bone, Ghina Jardali, Aurelie Choucair, Samy Ammari, et al.


  • Open Access

    Validation of a Pretrained Artificial Intelligence Model for Pancreatic Cancer Detection on Diagnosis and Prediagnosis Computed Tomography Scans

    by Laura Degand, Clément Abi-Nader, Alexandre Bône, Rebeca Vetil, Davide Placido, Piotr Chmura, Marc-Michel Rohé, Federico De Masi, Søren Brunak

    Purpose: To evaluate PANCANAI, a previously developed AI model for pancreatic cancer (PC) detection, on a longitudinal cohort of patients. In particular, aiming for PC detection on scans acquired before histopathologic diagnosis was assessed. Materials and Methods: The model has been previously trained to predict PC suspicion on 2134 portal venous CTs. In this study, the algorithm was evaluated on a retrospective cohort of Danish patients with biopsy-confirmed PC and with CT scans acquired between 2006 and 2016. The sensitivity was measured, and bootstrapping was performed to provide median and 95% CI. Results: The study included 1083 PC patients (mean age: 69 y ± 11, 575 men). CT scans were divided into 2 groups: (1) concurrent diagnosis (CD): 1022 CT scans acquired within 2 months around histopathologic diagnosis, and (2) prediagnosis (PD): 198 CT scans acquired before histopathologic diagnosis (median 7 months before diagnosis). The sensitivity was 91.8% (938 of 1022; 95% CI: 89.9–93.5) and 68.7% (137 of 198; 95% CI: 62.1–75.3) on the CD and PD groups, respectively. Sensitivity on CT scans acquired 1 year or more before diagnosis was 53.9% (36 of 67; 95% CI: 41.8–65.7). Sensitivity on CT scans acquired at stage I was 82.9% (29 of 35; 95% CI: 68.6–94.3). Conclusion: PANCANAI showed high sensitivity for automatic PC detection on a large retrospective cohort of biopsy-confirmed patients. PC suspicion was detected in more than half of the CT scans that were acquired at least a year before histopathologic diagnosis.


  • Baseline CT-derived tumor burden and liquid biopsy as biomarkers to predict survival in patients with metastatic solid cancer

    by Ghina Jardali, Littisha Lawrance, Lama Dawi, Jules Dupont, Othilie Gautier, Michèle Kind, Samy Ammari, Joya Hadchiti, Aurélie Choucair, Arnaud Bayle, et al.


  • Open Access

    Automatic Generation of Liver Virtual Models with Artificial Intelligence

    by Omar Ali, Alexandre Bône, Caterina Accardo, Belkacem Acidi, Amaury Facque, Paul Valleur, Chady Salloum, Marc-Michel Rohe, Irene Vignon-Clementel, Eric Vibert, et al.

    Objective: The clinical aim of this work is to predict intraoperative LRC from preoperative CT scans only. Summary of Background Data: Liver resection (LR) is the most prevalent curative treatment for primary liver cancer, yet overall mortality/morbidity rates remain elevated. The conventional definition and classification of LR complexity (LRC) lack inclusion of the disease-induced 3D anatomical surgery complexity. Methods: 3D models of the organ, tumors and blood vessels were generated from Deep Learning models trained on patients CT scans. The surgeons’ expertise on which anatomical factors lead to LRC was translated into a new anatomical frame of reference around the Hepatic Central Zone (HCZ). A fully automatic pipeline to generate the HCZ and quantify the tumors position relative to it was assessed. An AI model was then trained to predict LRC from a patient cohort for whom LRC was annotated at the end of each surgery. The AI-prediction was finally compared to prediction of surgeons that only saw the patient preoperative CT scan. Results: The 3D reconstructions are successfully evaluated on benchmark datasets. The HCZ is accurately generated for a variety of atypical vascular anatomies (dice score 82±4.6%). The automatic pipeline is successfully run on a 145 HCC patient cohort. The predicted LRC outperforms the surgeons’ individual and combined anticipated complexities (accuracy and AUC scores: 79.4±3.4% and 85.1±3.2% respectively). Conclusion: This automatic digital tool accurately predicts intraoperative LRC and paves the way for an innovative oncology surgery planning. This tool could help orient patients towards appropriate medical centers depending on the predicted LRC level.


  • Open Access

    Radiological diagnosis of hepatocellular carcinoma does not preclude biopsy before treatment

    by Bleuenn Brusset, Marion Jacquemin, Yann Teyssier, Gaël S. Roth, Nathalie Sturm, Matthieu Roustit, Alexandre Bône, Julien Ghelfi, Charlotte E. Costentin, Thomas Decaens


  • Ensembling Voxel-Based and Box-Based Model Predictions for Robust Lesion Detection

    by Noëlie Debs, Alexandre Routier, Clément Abi-Nader, Arnaud Marcoux, Alexandre Bône, Marc-Michel Rohé